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Abstract
Background: Research in vulnerable individuals must insure voluntariness and minimize negative reactions caused
by participation. This study aimed to describe consent and completion rate in young psychiatric patients in relation
to study components, degree of disability and to compare response to research participation in patients and controls.
Methods: Between 2012 and 2015, 463 patients with psychiatric disorders between the ages of 18–25 from the Dept.
of General Psychiatry at Uppsala University Hospital and 105 controls were recruited to donate data and samples to a
biobank. Consent and completion in relation to questionnaires, biological sampling of blood, saliva or feces, were
monitored. Both groups were also asked about their perceived disability and how research participation affected them.
Results: Most patients who participated consented to and completed questionnaires and blood sampling. The
majority also consented to saliva sampling, while less than half consented to collect feces. Of those who gave
consent to saliva and feces only half completed the sampling. Both patients and controls reported high voluntariness
and were positive to research participation. Within the patient group, those with greater perceived disability reported
greater distress while participating in research, but there was no difference in consent or completion rates or
level of regret.
Conclusions: With the described information procedures, psychiatric patients, regardless of perceived disability,
reported high voluntariness and did not regret participation in biobanking. Compared to questionnaires and
blood sampling, given consent was reduced for feces and completion was lower for both saliva and feces sampling.
Keywords: Biobanking, Disability, Ethics, General psychiatry, Voluntariness
Background
Current clinical practice in psychiatry is conducted
through subjective evaluation of phenotypes. Diagnostic
instruments, such as structured interviews and question-
naires, greatly improve the sorting of patients into valid
diagnostic groups for generalizations about appropriate
treatment. Biological markers are, however, absent and
an important dimension of diagnostics and basis for un-
derstanding disease etiology is missing. Recent research
suggest, for example, that interconnected links between
the immune system, the microbiome and the brain are
essential for normal brain functions, such as initiating and
regulating stress responses, emotions and behavior [1, 2].
The next step is to define clinical markers based on inte-
grated data that reflect biological pathways and look for
meaningful clinical differences in large representative
patient cohorts. Systematic collection of biological sam-
ples from patients within psychiatry are rare in contrast to
other medical specializations where biobanks provide a
foundation for excellent research with considerable poten-
tial to inform improved patient care. To provide a valid
basis for psychiatric research, sample collection must
reflect the population and include patients with significant
deficits in executive function, cognitive abilities and
emotional regulation. Complicated ethical aspects are a
central factor contributing to the slow development
within this area [3].
In 2012, our research group established an infrastruc-
ture, Uppsala Psychiatric Patient Samples (UPP), to enable
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systematic collection of data and biological material from
young adult patients newly remitted for ambulatory psy-
chiatric care. The data includes physical examination and
questions on sensitive topics such as experience of
physical and emotional trauma, self-harm, alcohol, and
illicit drug abuse. The biological material includes
blood tests, saliva collection and feces samples. In the
planning stages of the project, there was concern about
the feasibility and the ethical aspects of the project.
One concern was that there were too many questions
and that it would be difficult for patients to complete
the full protocol. Participation in the biological sampling
could be reduced by several factors, such as anxiety, blood
phobia, integrity concerns or low executive functioning.
Concern was raised that the questions could cause
emotional distress, that the patients would feel obliged
to partake or that patients would regret participation.
It is important to understand and minimize the dis-
tress that research may cause, more so in individuals
considered vulnerable. The American National Bioethics
Advisory Commission views the population with psy-
chiatric disorders as a ‘vulnerable’ one, but also con-
siders that not all people with psychiatric disorders are
‘vulnerable’ at all times and in all areas. Following this
argument Yanos et al. discusses the vulnerability among
persons with psychiatric disorders as a state, rather
than a trait, and presents evidence that vulnerability
must be evaluated in two dimensions: capacity and volun-
tariness, which must be considered while designing a
study [4]. Capacity is the degree to which participants are
able to comprehend informed consent. Voluntariness is
related to the power imbalance between investigator and
subject and is the act of free will with no coercion in
the recruitment of participants. Voluntariness is also
dependent on the ability to withdraw from the study at
any time [5]. Both capacity and voluntariness are extra
important in the case of studies based on biological
samples from a biobank. In this study, a broad consent
approach was selected as the most suitable option. This
consent involves a broad a decision to allow others to
decide based on general information that the future use
of the biobank samples would be used in research that
meet proper ethical and confidential standards [6, 7].
In a community-based study with a standardized psy-
chiatric interview [8], a small minority, 2.7%, reported
the interviews as quite distressing. In patients with psy-
chiatric disorders 9% reported anxiety after interview
study participation [9]. A review article summarizes that
a small minority experience distress during psychiatric
research, while distress is more common in studies
examining trauma [10]. A trauma-related study finds
that despite distress caused by participation, the experi-
ence as a whole was viewed as positive and interesting
and this held true even for patients who were highly
symptomatic for posttraumatic stress disorder (PTSD)
[11]. Further, ‘vulnerable’ individuals, in various domains
(economic, social, psychological, and physical health)
required to give a small blood sample through finger
pricks, had stronger emotional reactions to research par-
ticipation than less vulnerable but were not less willing
to continue participating [12].
To evaluate ethical and feasibility issues related to psy-
chiatric biobanking, this study aimed to describe consent
and completion rate in young psychiatric patients in
relation to study component; questionnaires or bio-
logical samples and in relation to degree of disability and
to compare response to research participation in patients
with controls. We hypothesized that patients are more
likely than healthy controls to report negative emotions
in response to research, however, they are more likely to
report research participation as meaningful, and equal or
less likely to regret participation. We also hypothesized
that degree of disability in psychiatric patients would
correlate negatively with consent and completion rates,





Between August 2012 and September 2015, all new
patients, 18–25 years of age, with primarily affective and
anxiety disorders, receiving ambulatory care at the
“Young Adults” section of Dept. of General Psychiatry at
Uppsala University Hospital were asked to participate in
Uppsala Psychiatric Patient Samples (UPP). The phase
and degree of illness was highly variable. Some patients
were remitted from other medical units already in stabi-
lized in treatment while others were untreated. The large
majority of patients reported current symptoms of
depression and/or anxiety. In total, 1119 patients were
approached and of them 463 (41.4%) accepted to partici-
pate. For those who gave consent, diagnoses were taken
from the medical records (457 patients). Table 1 shows
the participant characteristics of the patient group.
A control group was recruited from university em-
ployees and students. Controls were paid a modest sum
(250 SEK) to be subject to the same procedures and ques-
tionnaires as the patient group (see below). The control
group had an age range from 18 to 60, but for the purpose
of this paper we have included those between ages 18–30
to better match the patient group (n = 105). Table 1 shows
the characteristics of the control group.
Participant recruitment and informed consent
A research assistant personally informed patients with
oral and written information about UPP, answered ques-
tions and acquired signed consent. All patients were
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informed in writing that i) their participation was volun-
tary and would not influence their treatment; ii) samples
would be used for research on biological mechanisms
related to psychiatric disease and treatment and several
examples of possible research questions were given; iii)
new research questions using the samples must be
approved by the ethical comities and that new consent
from the patients may or may not be required; iv) that
coded samples may be sent to international laboratories
and data published in closed and open databases; v) The
identity of the participants is protected and not available
to persons outside the research group and that all
researches working with the data are bound by the same
confidentiality laws as hospital employees vi) patients
may once a year request their data and results free of
charge; vii) patients may leave the study at any time
point without providing an explanation and that the data
and samples would remain in the study as anonymous.
All patients were asked to sign a broad consent to
research that identify diagnostic biological markers (in-
cluding genetic, hormonal, intestinal microflora and
inflammatory markers) for disease to identify differences
between diagnostic groups, and to follow biological
changes during treatment. Patients were also asked spe-
cifically to consent by checking a box to each of the
following: collection of diagnostic information from
medical records, undergo thorough clinical assessment
(questionnaires and interview), physical examination,
blood test for analysis of hormones and changes in the
immune system and genetic analysis, repeated saliva
samples during a day, an adrenal function (dexameta-
sone) test, and in case of severe symptoms consent to
lumbar puncture, finally to consent to contact in the
future for monitoring and sampling.
The consent form was modified in 2013 and two ques-
tions were added, asking for consent to collect informa-
tion in national health and population registers and the
specific consent with a check box to provide feces, since
this was included among the biological samples but not
separately specified in the first form. Feces sampling was
reported by patients as more troublesome than blood
and saliva sampling and the modified consent form
allowed a post-hoc analysis of participants’ capacity to
decline participation. Furthermore, the consent to col-
lect lumbar fluid was modified so that patients would
better understand when this sampling would be applicable,
namely when symptom grade indicated clinical usage of
lumbar fluid for diagnostics. In a post-hoc analysis, con-
sent and completion rates were compared before and after
modifications were introduced in the consent form to
assess the impact of these changes on the decision to
participate.
The patient population had the option to opt out of
any of these procedures, while, for the sake of complete
data, the control group was asked to participate in all of
them, with the exception of the collection of cerebro-
spinal fluid sample, however this did not affect their
ability to withdraw from the study at any time. Controls
were recruited by oral and written information among
students and employees at the university. The same
research assistant as for the patients answered questions,
acquired signed consent and conducted the investiga-
tion. The written consent form for controls was shorter
and less detailed and participants were not given the
option to opt out of sections of the study.




Total (%) 463 (100)





Any major depressive disorder 134 (67.8)
Any bipolar disorder 58 (12.5)
Any anxiety disorder 278 (60.0)
Missing information 6 (1.3)
Level of education
University 211 (45.6)
Upper secondary school 191 (41.3)
9 year elementary school 31 (6.7)
Missing information 10 (2.2)
Controls






Any major depressive disorder 0
Any bipolar disorder 0
Any anxiety disorder 5 (4.7)
Missing information 5 (4.7)
Level of Education
University 101 (96.2)
Upper secondary school 0
9 year elementary school 1 (0.01)
Missing information 3 (0.03)
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Instruments
The questionnaires and the topics addressed are pre-
sented in Table 2.
Reactions to Research Participation Questionnaire (RRPQ)
RRPQ is an adaptation of the parent version, RRPQ-P
[13]. The items are not specific to any particular group
of research participants. The RRPQ-P was translated
with permission by the originators by three independent
researchers (among them authors MR and MW) and a
bilingual native English-speaking translator conducted a
back translation. There was only minor divergence and
the final version was decided by consensus. In the Swedish
version, 12 items were included. Items are rated from
1 = “I do not agree at all”, to 5 = “I agree completely”.
The scores for the three negative appraisal items (Q1, 4
and 6) were reversed before analysis. RRPQ was adminis-
tered after blood sampling as the last questionnaire. Feces
and saliva tests had in some cases not been completed.
Sheehan Disability Scale (SDS)
To measure perceived disability SDS [14] was used. SDS
is a brief self-report tool, with three items, where the
study subject rates the extent to which school/work,
social life and home/family life is impaired by the symp-
toms. It’s a valid, reliable measure of disability when
used in participants with psychiatric disorders [15–17].
Statistics
Statistics were performed using SPSS software version 21.
Data were estimated to be normally distributed if it ful-
filled two conditions; Skewness ratio (skewness divided
Table 2 Study components for which specific consent was requested, instruments and details about the method, number of items
or time to complete
Study Component Instruments Details
Clinical data
Diagnostic interview and clinical data Structured Clinical Interview for DSM-IV Axis I
Disorders- Clinical Version [21] or
Mini-International Neuropsychiatric Interview
[22, 23] from medical records
30–60 min




Blood EDTA-blood and serum 25 ml Conducted at the clinic
Saliva 6 samples over 1 day Conducted at home
Feces sampling 1 ml sample Conducted at home
Lumbar fluidb 10 ml Conducted at clinic
Adrenal function testb Dexametasone test Conducted at home
Questionnaires
Alcohol and drug use Alcohol Use Disorders Identification Test
and Drug Use Disorders Identification Test [24]
21 items
Depressive symptoms Montgomery Åsberg Depression Rating Scale [25–27] 9 items
Personality Swedish universities Scales of Personality [28] 91 items
Disability The Sheehan Disability Scale [29, 30] 5 items
Self harm Deliberate Self Harm Inventory: 9-Item Version [31] 9 items
Sleep quality Pittsburgh Sleep Quality Index [32] 19 items
Traumatic life events Early Trauma Inventory [33] 62 items
Sociodemografics, medical history,
heredity, menstruation patterns in
women, pain
Questions identical to those used in LifeGene (http://
www.lifegene.se) and EpiHealth (http://www.epihealth.se)
30 items
Gastrointestinal symptoms The Gastrointestinal Symptom Rating Scale [34] 15 items
Participant reactions Response to Research Participation Questionnaire [13, 35] 12 items
Follow-up
National registersb Registers concerning cause of death, disease,
pharmaceutical usage
Re-contactb Permission to contact follow-up.
aObtained only for the patient group. bNot initiated
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by the standard error of skewness between ± 2); visually
estimated normal distribution (histogram). SDS in
patients fulfilled assumptions of normality, but in the
control group, the SDS total and subscales and RRPQ-P
items in both groups were skewed. Group differences in
the individual RRPQ-P items were tested using Mann-
Whitney U test (mean rank). The correlations between
completion of saliva and feces collection and the SDS
were tested. The controls were not included in these
results, as they could not choose to opt-out of specific
study components.
Correlations were tested using Spearman’s bivariate rank
correlation. Statistical significance was defined at p < 0.05.
Results
Participation rates
Table 3 shows how the patients chose to consent to par-
ticipation in the different areas. The majority of patients
consented to access to medical records, health examination
and questionnaires as well as blood sampling. Among
those 95.9% who consented to blood tests, only four
patients, 0.9%, declined genetic analyses of these samples.
Consent for saliva collection was also high. When the spe-
cific question concerning feces was added in the consent
form, consent was lower than for saliva, 58% vs. 90.5%.
Post-hoc analysis of participation rates in relation to
modifications in consent forms
Completion rates were high for questionnaires and blood
sampling, but not for saliva and feces. The modification of
the consent form modification from a general consent to a
specific check-box for consent for feces donation resulted
in lower completion. Initially, when feces were collected
in conjunction with saliva without explicit consent, com-
pletion for feces was 37% among participants. When the
consent form was modified with a checkbox for feces col-
lection, completion was 48% among those who consented,
which is similar to saliva. Completion for feces in relation
to the whole population (consenting and non-consenting)
fell to 29% after this modification.
The modification of the consent form to specify that
lumbar puncture applied only when symptom grade
indicated clinical usage of lumbar fluid for diagnostics,
led to a higher consent rate from 45.0 to 71.1%. Analysis
of completion rates was not conducted for lumbar punc-
ture, adrenal function test, information collection in
national registers and future contact as these have not
yet been implemented.
Reactions to research participation in patients and controls
Complete data for RRPQ-P was available for 405 patients
and 93 controls. Item scores ranged from 1 to 5. Median
scores in all cases were equal or greater than 4. See Table 4
for answers on the RRPQ, both patients and controls
generally rated their experience as very positive. Differ-
ence between patients and controls in mean rank scores
for individual questions were tested and the only sig-
nificant difference was in “I was told the truth about
study” and “Knew I could skip questions” where
patients score higher than controls (z =−4.52, p < 0,001
and z = −5.24, p < 0.001 respectively).
Patients who donated feces before and after changes in
the consent form were compared for each question on
the RRPQ-P. Interestingly, despite generally positive
scores for both groups, there was significant difference
in question “I was glad I was in this study”, where pa-
tients who gave specific consent for feces sampling had
higher mean score (4.42 ± 0.81 vs. 4.15 ± 0.85, z = −3.46;
p < 0.001). Patients who gave consent for feces sampling
but did not follow through gave higher score for the
question “I chose to participate” than those who did
complete feces sampling (mean score 4.93 ± 0.33 vs 4.63
± 0.93; z = −2.95, p < 0.01).
Disability in psychiatric patients in relation to consent
and completion
Patients rated their disability higher than controls, total
SDS score 17.0 vs. 2.9 (z = −13.24, p < 0.001), and for
specific scales; school/work 5.98 vs. 0.99 (z = −13.16,
Table 3 Consent and completion rates for patients in Uppsala





ASKED TO PARTICIPATE IN UPP 1119 (100)
Declined to participate 656 (58.6)
PARTICIPANTS IN UPP 463 (41.4)
Included in UPP 463 (100) n/a
Access to medical records 457 (98.5) 457 (100)
Questionnaires and
health examination
460 (99.1) 460 (100)
Blood test, hormone 445 (95.9) 435 (97.6)
Blood test, genetics 441 (95.0) 435 (98.6)
Saliva 420 (90.5) 202 (47.9)
Feces (n = 299)b n/a 111 (37)
Feces (n = 164)b 98 (59.8)b 47(48)
Adrenal Function 387 (83.4) ni
Lumbar puncture (n = 299) 134 (44.8)b ni
Lumbar puncture (n = 164)b 118 (72)b ni
Collection of information in the national
health and population registers (n = 164)
156 (94)b ni
To be contacted in the future 442 (95.2) ni
ni Not been implemented. aPercentage of study participants who consented
and completed test presented. bNumber of eligible participants is lower due
to a modified consent form after the first 298 study participants
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p < 0.001), social life 5.86 vs. 1.05 (z = −12.89, p < 0.001)
and home/family 5.35 vs. 0.87 (z = −13.58, p < 0.001), indi-
cating greater potential vulnerability in patients. Analysis
of patients’ disability in relation to consent to specific
parts of the study showed, in contrast to the hypothesis,
small positive correlations between higher degree of
disability and given consent for adrenal function test
(0.10 p < 0.05) and contact in the future (0.11, p < 0.05).
There was no correlation between completed study
components and disability as measured with SDS.
Disability in psychiatric patients in relation to reactions to
research participation
In the patient group, a correlation was found between
responses that reflect higher distress on the RRPQ ques-
tion, “Being in the study made me sad or upset”, and
higher disability, measured as total SDS score (r = 0.20,
p < 0.001), and with specific SDS subscales; school/work
(r = 0.18, p < 0.001) social life (r = 0.19, p < 0.001), and
home/family life, (r = 0.18, p < 0.001). No correlation was
found between perceived disability and participation
regret (r = 0.02, p = 0.71).
Discussion
Psychiatric research must include vulnerable individuals
in order to be valid and this involves ethical risks [3].
Young adult psychiatric patients who participated in
psychiatric biobank sampling reported high voluntari-
ness and did not regret participation. Patients did not
differ from controls in this matter, despite a large differ-
ence in psychiatric symptoms and perceived disability
between the groups. When individual questions were
compared, the only significant difference between the
groups was found for the question “I was told the truth
about the study”, where although both groups had high
scores, the patient group scored higher, and therefore
considered themselves to be better informed, than their
control counterparts. This difference may be due to dif-
ferences in recruitment procedures. Before study start
and continually throughout the study, ethical concerns
and procedural barriers in obtaining signed consent were
discussed within the research group and clinic. We
believe that the ethical awareness of the research assist-
ant contributed greatly to engaging patients at this acute
stage. Monitoring subjective experience of research par-
ticipation provided an important validation of the
informed consent procedure applied in this setting and
this method can easily be applied in other research
contexts.
Patients giving consent largely participated in both
questionnaires and blood tests. There was no difference
in consent given for genetic compared to hormone ana-
lysis of blood, which is interesting since ethical commit-
tees often consider genetic analyses more ethically
challenging. Participation in saliva and feces collection
was much lower than for blood, While were are not
aware of earlier studies concerning feces donation, an
earlier general population survey indicates that willing-
ness to donate saliva is higher than for blood [18]. Par-
ticipation in saliva and feces collection required patients
to go home with tubes and return with samples to the
clinic within a limited time frame. Consent given for
saliva sampling was much higher that completion. One
explanation might be that the sampling method requires
higher motivation and/or executive abilities. Consent for
feces collection was lower than for saliva, indicating that
this may be regarded as more uncomfortable. The com-
pletion rate for those who gave consent was similar to
that of saliva, approximately half. Interestingly, a higher
percentage of patients completed feces sampling when
Table 4 Mean response to each question on the Reactions to Research Participation Questionnaire in patients and controls
Brief item description Patients Controls Z
Mean SD Mean SD
Q1 Being in the study was boringa 4.26 0.89 4.24 0.76 −0.71
Q2 Glad I was in this study 4.23 0.84 4.15 0.81 −1.13
Q3 My choice (could have said no) 4.82 0.59 4.85 0.53 −0.21
Q4 Participation made me feel sad/upseta 4.59 0.78 4.71 0.66 −1.510
Q5 The things I said will stay private 4.29 0.98 4.47 0.93 −1.96
Q6 Sorry I was in this studya 4.90 0.34 4.89 0.32 −0.629
Q7 Feel good about self 3.57 1.18 3.81 0.81 −1.28
Q8 Was told truth about study 4.71 0.65 4.38 0.86 −4.53***
Q9 Feel good about helping others 4.68 0.72 4.68 0.62 0.68
Q10 Knew I could skip questions 4.13 1.21 3.30 1.48 −5.24***
Q11 Knew I could stop at any time 4.62 0.82 4.74 0.72 −1.67
Q12 Knew I could take a break 4.32 1.06 4.11 1.26 −1.36
areversed score ***p < 0.0001
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not specifically asked for consent. This may reflect a dif-
ference in the perceived right to choose in the two situa-
tions. It is well described that voluntariness is influenced
by implicit power in the relationship between partici-
pants and investigators in research [4]. Patients not
given the opportunity to decline feces sampling might
have had difficulties rejecting it when they already were in
the study. Accordingly, patients, who did not complete
the collection of feces, although they had consented, had a
stronger feeling of voluntariness than those who con-
sented and completed. Furthermore, patients who were
asked for consent were actually happier to participate than
those who were not asked, indicating that more informa-
tion may be negative for participation but positive for the
subject’s participation experience.
Within the patient group, there was a positive cor-
relation between the levels of distress caused by research
participation and perceived disability, although there was
no such correlation in the item of measuring the feeling
of regret. These results are similar to earlier studies
where distress was linked with vulnerability but without
lesser willingness to continue with participation [12].
Additionally, perceived disability contributed to equal or
higher consent and completion rates. This is encouraging
as the validity of the sample collection depends on the
inclusion of patients with more severe disease states
and our results indicate that this can be achieved while
preserving the autonomy of individual patients.
The study has several strengths, it is the largest to date
concerning a general psychiatric population and includes
data from controls, data was collected prospectively and
diagnostic methods were standardized. The results are
based on an outpatient population with primarily anxiety
and affective disorders. A limitation of the study is that
the results are not necessarily applicable to inpatients
and/or patients with psychotic disorders. A second limi-
tation is that data was not available on patients who
declined participation in UPP from the start. Further
research is needed to identify reasons behind declining
participation. The Swedish population reports high levels
of trust in public institutions and willingness to donate
blood for research [19, 20]. Broad consent is both widely
implemented and accepted in the Scandinavian countries
when compared to most other European countries and
therefore our findings may not be generalizable to other
countries [20].
Conclusion
The importance of evaluating the impact of research on
its participants should not be understated. Ethical com-
mittees and researchers have a responsibility to both
ensure high quality research and protect the participants,
more so if potentially vulnerable. This study describes a
method for including young adult patients seeking help
for psychiatric disorders in bio-banking with broad con-
sent. In this setting, patients report high levels of volun-
tariness and understanding of the information given
and overwhelmingly positive participation experience.
Although disability is connected to distress during re-
search participation, it does not reduce the rate of consent
or completion and patients do not regret participation.
When comparing patients with a control group no signifi-
cant negative difference in emotional response to research
participation was found. Interest in biological mechanisms
related to psychiatric disorders is growing and these
results indicate that careful information and consent pro-
cedures allow for representative sample collection, volun-
tariness and minimal negative reactions in this vulnerable
patient group.
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